 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
ImmunoGen
IMGN
conference date: November 2, 2023 @ 5:00 AM Pacific Time
ImmunoGen to Be Acquired by AbbVie [November 30, 2023]
ImmunoGen Price Run-Up Driven by Potential Trial Data [Feb. 6, 2018 at SA]
AML Therapies, Part 2: Agios and Immunogen [September 29, 2016 at Seeking Alpha]
ImmunoGen Oversold Despite Strong Pipeline [July 7, 2016 at Seeking Alpha]
| 2023 | |||
| ImmunoGen Q1 2023 |
ImmunoGen Q2 2023 |
ImmunoGen Q3 2023 |
|
| April 28, 2023 | July 31, 2023 | Nov. 2, 2023 | |
| 2022 | |||
| ImmunoGen Q1 2022 |
ImmunoGen Q2 2022 |
ImmunoGen Q3 2022 |
ImmunoGen Q4 2022 |
| May 6, 2022 | July 29, 2022 | Nov. 4, 2022 | March 1, 2023 |
| 2021 | |||
| ImmunoGen Q1 2021 |
ImmunoGen Q2 2021 |
ImmunoGen Q3 2021 |
ImmunoGen Q4 2021 |
| May 10, 2021 | July 30, 2021 | Oct. 29, 2021 | Feb. 25, 2022 |
| 2020 | |||
| ImmunoGen Q1 2020 |
ImmunoGen Q2 2020 |
ImmunoGen Q3 2020 |
ImmunoGen Q4 2020 |
| May 1, 2020 | July 31, 2020 | Nov. 6, 2020 | Feb. 12, 2021 |
| 2019 | |||
| ImmunoGen Q1 2019 |
ImmunoGen Q2 2019 |
ImmunoGen Q3 2019 |
ImmunoGen Q4 2019 |
| May 3, 2019 | August 2, 2019 | Nov. 1, 2019 | Feb. 14, 2020 |
2018 |
|||
| ImmunoGen Q4 2018 |
|||
May 4, 2018 |
July 27, 2018 |
Nov. 2, 2018 |
Feb. 8, 2018 |
2017 |
|||
May 5, 2017 |
July 28, 2017 |
Nov. 3, 2017 |
Feb. 9, 2018 |
2016 |
|||
04/29/2016 |
08/04/2016 |
10/28/2016 |
02/17/2017 |
Immunogen (IMGN) is a clinical-stage biotechnology company specializing in ADC's (antibody-drug conjugates) for cancer and other diseases.
sold my last on Dec. 17, 2019
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| ALXN |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BMY |
| CLDX |
| CDTX |
| GILD |
| GLYC |
| ILMN |
| INCY |
| INO |
| IONS |
| ISRG |
| MCHP |
| MRNA |
| PLX |
| REGN |
| RNA |
| SAGE |
| SANA |
| SGEN |
| SYRS |
| TSTV |
| VRTX |
| VSTM |
| WBA |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2023 William P. Meyers